Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 99Leukemia, Myeloid, Acute 98Leukemia 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Myeloproliferative Disorders 71Leukemia, Lymphocytic, Chronic, B-Cell 69Leukemia, Myeloid, Accelerated Phase 66Leukemia, Myeloid, Chronic-Phase 65Hodgkin Disease 65Multiple Myeloma 63Lymphoma, Non-Hodgkin 63Lymphoma, Follicular 58Congenital Abnormalities 58Lymphoma, Mantle-Cell 56Leukemia, Myelomonocytic, Chronic 55Lymphoma, Large B-Cell, Diffuse 54Blast Crisis 52Lymphoma, B-Cell, Marginal Zone 51Burkitt Lymphoma 51Lymphoma, Large-Cell, Immunoblastic 49Lymphoma 46Primary Myelofibrosis 44Neoplasms, Plasma Cell 36Myelodysplastic-Myeloproliferative Diseases 36Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 34Lymphoma, T-Cell, Cutaneous 33Sezary Syndrome 31Mycosis Fungoides 31Anemia, Refractory, with Excess of Blasts 31

Interventions

luspatercept 4Biopsy 4Lenalidomide 3Epoetin Alfa 3Cyclophosphamide 3Busulfan 3ruxolitinib 2fludarabine 2Filgrastim 2Cyclosporine 2Antilymphocyte Serum 2AP 1903 reagent 2ACE-011 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1vactosertib 1trametinib 1thymoglobulin 1siltuximab 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia × Peripheral Blood Stem Cell Transplantation × Myeloid × Clear all
NCT00301912 2012-10-02

Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

University of California, San Francisco

Phase 2 Withdrawn
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Blast Crisis, Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡